Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Anemia In Elderly Industry By 2029?

There has been remarkable expansion in the market size of anemia in the elderly over the recent past. The market is projected to rise from $2.75 billion in 2024 to $2.99 billion in 2025, with a compound annual growth rate (CAGR) of 8.8%. Factors such as nutritional insufficiencies, presence of chronic diseases, inflammation, disorders of the bone marrow, and blood loss are responsible for the growth experienced in the historic period.

The market size for anemia in the elderly is set to experience substantial growth in the upcoming years. It is forecasted to reach $4.22 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period can be linked to factors such as an aging population, an increase in chronic disease cases, advancements in diagnostic methods, enhanced awareness about health care, and better treatment accessibility. The forecast period will also see significant trends such as diagnostics powered by AI, wearable devices for health monitoring, sophisticated tools for blood analysis, integration of telehealth, and solutions for personalized medicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20711&type=smp

Which Factors Are Steering Growth In The Anemia In Elderly Market?

Advancements in the anemia concerning the elderly market are anticipated to be influenced by the rise in the aging population. This group is characterized by a surge in the number and percent of individuals who are 65 years old and above in a specific society or worldwide. Factors such as lengthier life expectancy, dwindling birth rates, and the inevitable aging of broad groups, contribute to the augmented elderly population. This uptick corresponds with an escalation in the occurrence of chronic and age-related ailments, which are substantial contributors to anemia among the aged populace. This, in turn, prompts the need for anemia’s diagnosis, governance, and therapy, thus pushing the market’s expansion. The Office for National Statistics (ONS), a governmental entity headquartered in the UK, reported in July 2024 that the UK’s count of people who are 65 or older climbed from 11 million in 2021 to 12.7 million in 2022. Hence, the burgeoning elderly populace is the propellant for the growth of the anemia in a senior citizen market.

Which Segment Accounts For The Largest Share In The Anemia In Elderly Market?

The anemia in elderlymarket covered in this report is segmented –

1) By Product Type: Tablets, Injectable

2) By Treatment: Iron Supplements, Erythropoietin Or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, Folic Acid Supplements

3) By Route Of Administration: Oral, Parenteral

4) By End User: Hospital pharmacy, Online Pharmacy, Retail pharmacy

Subsegments:

1) By Tablets: Iron Supplements; Vitamin B12 Supplements; Folic Acid Tablets; Erythropoiesis-Stimulating Agents (ESAs) Tablets

2) By Injectable: Iron Injections; Vitamin B12 Injections; Erythropoiesis-Stimulating Agents (ESAs) Injections; Folic Acid Injections

Which Long-Term Trends Will Play A Crucial Role In The Anemia In Elderly Market?

Prominent businesses in the market for anemia in the elderly are emphasizing technological innovation, incorporating approaches such as personalized therapies. These strategies aim to refine the method of treatment, elevate patient results, decrease adverse effects, and boost overall healthcare productivity. Personalized therapies are health treatments tailored to an individual’s unique characteristics. To illustrate, Cadila Pharmaceuticals, a company from India focusing on pharmaceuticals, unveiled the Redshot FCM, a new iron injection, in March 2024. This innovation is focused on assisting those with iron deficiency anemia who suffer from oral iron intolerance. It is an intravenous iron solution that supplies ample iron and presents an exceptional safety standard. The injection uses a progressive Ferric Carboxymaltose formula to enhance iron delivery and absorption. Redshot FCM exemplifies a commitment to elevating healthcare by producing personalized therapies. These approaches take into account the distinct profiles of each patient, resulting in improved treatment results for iron deficiency anemia.

Who Are The Dominant Players In The Anemia In Elderly Market Today?

Major companies operating in the anemia in elderly market are Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limted, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, MegaPro Biomedical Co Ltd

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report

What Regional Factors Are Accelerating Growth In The Anemia In Elderly Market?

North America was the largest region in the anemia in elderly market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia in elderly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=20711&type=smp

Browse Through More Reports Similar to the Global Anemia In Elderly Market 2025, By The Business Research Company

Anemia And Other Blood Disorder Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Hematology Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/hematology-drugs-global-market

Chemotherapy Induced Anemia Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model